Blood–brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia

B Hussain, C Fang, J Chang - Frontiers in neuroscience, 2021 - frontiersin.org
The blood–brain barrier (BBB) plays a vital role in maintaining the specialized
microenvironment of the neural tissue. It separates the peripheral circulatory system from the …

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke …

PB Gorelick, A Scuteri, SE Black, C DeCarli… - stroke, 2011 - Am Heart Assoc
Background and Purpose—This scientific statement provides an overview of the evidence
on vascular contributions to cognitive impairment and dementia. Vascular contributions to …

Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: an aging effect

W Cai, K Zhang, P Li, L Zhu, J Xu, B Yang, X Hu… - Ageing research …, 2017 - Elsevier
Current understanding on the mechanisms of brain injury and neurodegeneration highlights
an appreciation of multicellular interactions within the neurovascular unit (NVU), which …

astrocytes in Alzheimer's disease and other age‐associated dementias: a supporting player with a central role

CJ Garwood, LE Ratcliffe, JE Simpson… - Neuropathology and …, 2017 - Wiley Online Library
Astrocytes have essential roles in the central nervous system and are also implicated in the
pathogenesis of neurodegenerative disease. Forming non‐overlapping domains, astrocytes …

The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

C Iadecola - Acta neuropathologica, 2010 - Springer
There is increasing evidence that cerebrovascular dysfunction plays a role not only in
vascular causes of cognitive impairment but also in Alzheimer's disease (AD). Vascular risk …

Early neuronal accumulation of DNA double strand breaks in Alzheimer's disease

NM Shanbhag, MD Evans, W Mao, AL Nana… - Acta neuropathologica …, 2019 - Springer
The maintenance of genomic integrity is essential for normal cellular functions. However, it is
difficult to maintain over a lifetime in postmitotic cells such as neurons, in which DNA …

Mitochondrial dysfunction in Alzheimer's disease: a biomarker of the future?

SM Bell, K Barnes, M De Marco, PJ Shaw, L Ferraiuolo… - Biomedicines, 2021 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia worldwide and is
characterised pathologically by the accumulation of amyloid beta and tau protein …

The impact of obesity on neurodegenerative diseases

JN Mazon, AH de Mello, GK Ferreira, GT Rezin - Life sciences, 2017 - Elsevier
Neurodegenerative diseases are a growing health concern. The increasing incidences of
these disorders have a great impact on the patients' quality of life. Although the mechanisms …

Mechanistic link between vitamin B12 and Alzheimer's disease

AA Lauer, HS Grimm, B Apel, N Golobrodska, L Kruse… - Biomolecules, 2022 - mdpi.com
Alzheimer's disease (AD) is the most common form of dementia in the elderly population,
affecting over 55 million people worldwide. Histopathological hallmarks of this multifactorial …

Oxidative Stress and β-Amyloid Protein in Alzheimer's Disease

Z Cai, B Zhao, A Ratka - Neuromolecular medicine, 2011 - Springer
Oxidative stress has been proposed to be an important factor in the pathogenesis of
Alzheimer's disease (AD) and contributed to β-amyloid (A β) generation. Interaction between …